Inflammatory Disease and Glaucoma

  • Sunita Radhakrishnan
  • Emmett T. CunninghamJr
  • Andrew Iwach


Elevated intraocular pressure (IOP) is a common, but challenging complication of ocular inflammation. When IOP elevation in the setting of uveitis is temporary and does not damage the optic nerve, the term uveitis-related ocular hypertension is most appropriate. Uveitic “glaucoma” must be reserved for cases of uveitis in which elevated IOP is associated with optic nerve damage, which manifests as changes in the optic nerve structure and/or the presence of visual field defects. The overall prevalence of secondary glaucoma in all forms of uveitis has been reported to be between 5 and 19% in adults and from 5 to 13.5% in children. Anterior uveitis, older age at presentation, and chronic inflammation are all related to a higher prevalence of uveitic glaucoma. Certain types of uveitis, such as herpetic keratouveitis and anterior uveitis, associated with Juvenile Idiopathic Arthritis are also associated with a higher prevalence of secondary glaucoma.


Ocular Hypertension Trabecular Meshwork Anterior Uveitis Angle Closure Primary Open Angle Glaucoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Moorthy RS, Mermoud A, Baerveldt G, et al. Glaucoma associated with uveitis. Surv Ophthalmol. 1997;41:361–394.CrossRefPubMedGoogle Scholar
  2. 2.
    Reddy S, Cubillan LDP, Havakimyan A, Cunningham ET. Inflammatory ocular hypertension syndrome (IOHS) in patients with syphilitic uveitis. Br J Ophthalmol. 2007;91:1610–1612.CrossRefPubMedGoogle Scholar
  3. 3.
    Westfall AC, Lauer AK, Suhler EB, Rosenbaum JT. Toxoplasmosis retinochoroiditis and elevated intraocular pressure. J Glaucoma. 2005;14:3–10.CrossRefPubMedGoogle Scholar
  4. 4.
    Warwar RE, Bullock JD, Ballal D. Cystoid macular edema and anterior uveitis associated with Latanoprost use: experience and incidence in a retrospective review of 94 patients. Ophthalmology. 1998;105:263–268.CrossRefPubMedGoogle Scholar
  5. 5.
    Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. Am J Ophthalmol. 1999;127:602–604.CrossRefPubMedGoogle Scholar
  6. 6.
    Spencer NA, Hall AJ, Stawell RJ. Nd:Yag laser iridotomy in uveitic glaucoma. Clin Experiment Ophthalmol. 2001;29:217–219.CrossRefPubMedGoogle Scholar
  7. 7.
    Retisert (Bausch & Lomb/Control Delivery Systems). Lim LL, Smith JR, Rosenbaum JT. Curr Opin Invest Drugs. 2005;6:1159–1167Google Scholar
  8. 8.
    Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol. 1999;128:434–439.CrossRefPubMedGoogle Scholar
  9. 9.
    Towler HMA, Bates AK, Broadway DC, et al. Primary trabeculectomy with 5-fluorouracil for glaucoma secondary to uveitis. Ocul Immunol Inflamm. 1995;3:163–170.CrossRefGoogle Scholar
  10. 10.
    Prata JA, Neves RA, Minckler DS, et al. Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg Lasers. 1994;25:616–620.Google Scholar
  11. 11.
    Noble J, Derzko-Dzulynsky L, Rabinovitch T, Birt C. Outcome of trabeculectomy with intraoperatieve mitomycin C for uveitic glaucoma. Can J Ophthalmol. 2007;42:89–94.PubMedGoogle Scholar
  12. 12.
    Towler HM, McCluskey P, Shaer B, et al. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology. 2000;107:1822–1828.CrossRefPubMedGoogle Scholar
  13. 13.
    Jampel HD, Jabs DA, Quigley HA. Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol. 1990;109:168–173.PubMedGoogle Scholar
  14. 14.
    Patitsas CJ, Rockwood EJ, Meisler DM, et al. Glaucoma filtering surgery with postoperative 5-Fluorouracil in patients with intraocular inflammatory disease. Ophthalmology. 1992;99:594–599.PubMedGoogle Scholar
  15. 15.
    Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62–69.CrossRefPubMedGoogle Scholar
  16. 16.
    Ceballos EM, Parrish RK II, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. 2002;109:2256–2260.CrossRefPubMedGoogle Scholar
  17. 17.
    Freedman SF, Rodriguez-Rosa RE, Rojas MC, Enyedi LB. Goniotomy for glaucoma secondary to chronic childhood uveitis. Am J Ophthalmol. 2002;133:617–621.CrossRefPubMedGoogle Scholar
  18. 18.
    Miserocchi E, Carassa RG, Bettin P, Brancato R. Viscocanalostomy in patients with glaucoma secondary to uveitis: preliminary report. J Cataract Refract Surg. 2004;30:566–570.CrossRefPubMedGoogle Scholar
  19. 19.
    Williams RD, Hoskins HD, Shaffer RN. Trabeculodialysis for inflammatory glaucoma: a review of 25 cases. Ophthalmic Surg. 1992;23:36–37.PubMedGoogle Scholar
  20. 20.
    Kanski JJ, McAllister JA. Trabeculodialysis for inflammatory glaucoma in children and young adults. Ophthalmology. 1985;92:927–930.PubMedGoogle Scholar
  21. 21.
    Minckler D, Baerveldt G, Ramirez MA, et al. Clinical results with the Trabectome, a novel surgical device for treatment of open-angle glaucoma. Trans Am Ophthalmol Soc. 2006;104:40–50.PubMedGoogle Scholar
  22. 22.
    Jones R, Rhee DJ. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17:163–167.PubMedGoogle Scholar
  23. 23.
    Clark A. Steroids, ocular hypertension, and glaucoma. J Glaucoma. 1995;4:354–369.PubMedGoogle Scholar
  24. 24.
    Armaly MF. Statistical attributes of the steroid hypertensive response in the clinically normal eye. I. The demonstration of three levels of response. Invest Ophthalmol. 1965;4:187–197PubMedGoogle Scholar
  25. 25.
    Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965;26:198–205.Google Scholar
  26. 26.
    Jonas JB, Degenrigh RF, Kreissig I, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 2005;112:593–598.CrossRefPubMedGoogle Scholar
  27. 27.
    Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90:999–1003.CrossRefPubMedGoogle Scholar
  28. 28.
    Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007;125:1478–1485.CrossRefPubMedGoogle Scholar


  1. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. Sep 2005;140(3):509–516.Google Scholar
  2. McCannel CA, Holland GN, Helm CJ et al. Causes of uveitis in the general practice of ophthalmology. Am J Ophthalmol. 1996;121:35–46.PubMedGoogle Scholar
  3. Rothova A, Buitenhuis HJ, Meenken C et al. Uveitis and systemic disease.Google Scholar
  4. Tay-kearney M, Schwam BL, Lowder C et al. Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996;121:47–56.PubMedGoogle Scholar
  5. Weiner A, BenEstra D. Clinical patterns and associated conditions in chronic uveitis. Am J Ophthalmol. 1991;112:151–158.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Sunita Radhakrishnan
    • 1
  • Emmett T. CunninghamJr
    • 2
    • 3
  • Andrew Iwach
    • 4
  1. 1.Glaucoma Center of San Francisco & Glaucoma Research .and Education GroupSan FranciscoUSA
  2. 2.Stanford University School of MedicineStanfordUSA
  3. 3.Department of OphthalmologyThe Uveitis Service, California Pacific Medical CenterSan FranciscoUSA
  4. 4.Department of OphthalmologyGlaucoma Center of San Francisco, University of California – San FranciscoSan FranciscoUSA

Personalised recommendations